- Healthcare Economist a top health economics blogby Jason Shafrin (Healthcare Economist) on April 2, 2025
Healthcare Economist was once again named one of the Top 10 Health Economics Blogs and Websites in 2025 (#4) by Feedspot. Feedspot also named this blog as a top 50 Best Public Health Blogs and Websites in 2025 (#13). Exciting to keep the blogging […]
- Critique of ICER’s Special Assessment to Inform CMS Drug Price Negotiation: Eliquis and Xareltoby Jason Shafrin (Healthcare Economist) on April 1, 2025
That is the title of a new FTI Consulting white paper co-authored with Kyi-Sin Than. The abstract is below. In October 2023, ICER released a special assessment aimed at influencing CMS drug price negotiations for two direct-acting oral […]
- TeamHealth, Array Behavioral Care Partner to Advance Emergency Behavioral Health Treatmentby Marissa Plescia (MedCity News) on April 1, 2025
A new partnership between TeamHealth and Array Behavioral Care aims to enhance mental health support in emergency departments. The post TeamHealth, Array Behavioral Care Partner to Advance Emergency Behavioral Health Treatment appeared first on […]
- An AI Biotech Hauls In $600M, Plus More Funding Highlights to Close 1Q 2025by Frank Vinluan (MedCity News) on April 1, 2025
Isomorphic Labs’ financing led the way for first quarter 2025 financings, but it comes amid headwinds for the biotech sector. Biotech financing activity has been slowing down, analysts say. The post An AI Biotech Hauls In $600M, Plus More Funding […]
- Pivot: Discussing the Impact of a Proposed HIPAA Security Updateby Arundhati Parmar (MedCity News) on April 1, 2025
All healthcare entities storing or transferring patient health information needs to be aware of a proposed update to HIPAA tackling data encryption. Bryan Marlatt, chief regional officer at CyXcel The post Pivot: Discussing the Impact of a Proposed […]
- Fight Clinician Burnout with Better Interoperability Built on Clear Communicationby Ashley Franks (MedCity News) on April 1, 2025
Reversing this trend requires connecting disparate systems to enhance interoperability and communication and achieve more efficient, cohesive workflows. Implementing the infrastructure to streamline collaboration and reduce administrative burden […]
- The Key to Solving Medication Errors is At The Intersection of Technology and Standardsby Julian Herbert (MedCity News) on April 1, 2025
By integrating industry standards into e-prescribing software, prescribing organizations can reduce errors to improve patient outcomes and lessen the burden of medication-related errors on healthcare systems. Here’s a look at the new National […]
- Which Biopharma Startups Made the Cut for INVEST Pitch Perfect?by Stephanie Baum (MedCity News) on April 1, 2025
The conditions the biopharma companies target include sepsis, antimicrobial resistance, and acute infectious conjunctivitis. The post Which Biopharma Startups Made the Cut for INVEST Pitch Perfect? appeared first on MedCity News.
- America’s Aging Crossroads: Will We Rise to the Challenge or Fall Behind?by Adam S. Herbst (MedCity News) on April 1, 2025
This is not just about today’s older adults — it’s about the next 50 years. If we design a smarter, more sustainable system now, we will all benefit when our time comes. The post America’s Aging Crossroads: Will We Rise to the Challenge or […]
- Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffsby Katie Adams (MedCity News) on March 31, 2025
March has seen a slew of executive hires, exits and layoffs across the healthcare industry. For example, providers like Providence and Geisinger have appointed new C-suite leaders, and companies like Blue Shield of California and Evernorth have […]
- Talkspace Introduces AI-Powered Personalized Podcastsby Marissa Plescia (MedCity News) on March 31, 2025
Talkspace introduced Talkcast on Monday, an AI-powered feature that allows therapists to generate personalized podcast episodes for clients. The post Talkspace Introduces AI-Powered Personalized Podcasts appeared first on MedCity News.
- Vertex Cell Therapy Misses in the Clinic, But It Has Other Shots on the Type 1 Diabetes Goalby Frank Vinluan (MedCity News) on March 31, 2025
Vertex Pharmaceuticals is stopping development of VX-264, an experimental cell therapy/medical device treatment for type 1 diabetes, after an early look at Phase 1/2 data fell short of efficacy goals. This program came from a $950 million […]
- Economic impact of sotagliflozin among patients with heart failure and type 2 diabetesby Jason Shafrin (Healthcare Economist) on March 31, 2025
That is the title of a new paper with Shanshan Wang, Jaehong Kim, and Slaven Sikirica that has the subtitle “Budget impact analysis from the US payer perspective.” That abstract is below: BACKGROUND:Heart failure (HF) is a leading cause of […]
- How Real-World Data Can Support Label Extension And Safer Use Of Novel Therapiesby Jenna Phillips (MedCity News) on March 31, 2025
Engaging in data sharing, observational cohort research, and deeper analysis of available data to yield further insights can drive improved results for patients, making label and cohort extension faster and more robust. The post How Real-World Data […]
- Two Chairs Expands Mental Health Services to 19 More Statesby Katie Adams (MedCity News) on March 30, 2025
Two Chairs, which offers hybrid behavioral health care, expanded its presence from three states to 22 states. This expansion gives millions of people access to therapy services, as Two Chairs’ services are now available to 75% of the U.S. […]
- What’s Private Equity’s Impact on Intellectual and Developmental Disability Services?by Marissa Plescia (MedCity News) on March 30, 2025
A new report from the Private Equity Stakeholder Project reveals that private equity firms have been increasingly acquiring intellectual and developmental disability providers and implementing cost-cutting strategies that reduce care quality. The […]
- PCR Comes to the Home With FDA Authorization of Visby’s OTC Sexual Health Testby Frank Vinluan (MedCity News) on March 30, 2025
The FDA granted marketing authorization to a Visby Medical at-home PCR test for three common sexually transmitted infections. The Visby test yields results in about 30 minutes. The post PCR Comes to the Home With FDA Authorization of Visby’s OTC […]
- The Case for 340B Done Rightby Clifford W. Knights (MedCity News) on March 30, 2025
It’s critical that healthcare organizations delivering on the program’s promise not be torpedoed by the “bad actors” The post The Case for 340B Done Right appeared first on MedCity News.
- Unlocking the Potential: Medication Assisted Therapies for Opioid Substance Use Disorder in Correctional Settingsby Jeffrey Alvarez (MedCity News) on March 30, 2025
To reduce overdose rates in the U.S., leaders must recognize the impact of medication-assisted treatment in correctional facilities. The post Unlocking the Potential: Medication Assisted Therapies for Opioid Substance Use Disorder in Correctional […]
- Linksby Jason Shafrin (Healthcare Economist) on March 28, 2025
Measles outbreak expands to 19 states. Commercial health plan coverage of accelerated approval drugs…and a recent case study. Extending IRA drug price negotiation to commercial plans? ‘Kennedy Turns to a Discredited Vaccine Skeptic for Autism […]
- Report: How Medicaid/SNAP Cuts Could Affect the Economyby Marissa Plescia (MedCity News) on March 28, 2025
Medicaid and SNAP cuts could lead to 1 million jobs lost in just 2026, according to a new report from the Commonwealth Fund and the George Washington University Milken Institute School of Public Health. The post Report: How Medicaid/SNAP Cuts Could […]
- Most Healthcare Providers Remain Highly Vulnerable to Ransomware Attacksby Katie Adams (MedCity News) on March 28, 2025
About 90% of healthcare organizations are insecurely connected to the internet and running systems vulnerable to exploitation by ransomware gangs, according to new research. It also found that 78% of providers have made ransomware payments of […]
- Novo Nordisk Lands Lexicon Pharma Obesity Drug With Potential to Pair With GLP-1sby Frank Vinluan (MedCity News) on March 28, 2025
Novo Nordisk gets global rights to Lexicon Pharmaceuticals’ LX9851, an oral small molecule with a first-in-class approach to sparking weight loss. The licensing agreement comes months after Lexicon reported encouraging preclinical data from tests […]
- How Community Health Programs are Reducing 911 Calls and Helping Patients Before Emergenciesby Joe Graw (MedCity News) on March 28, 2025
By focusing on prevention, collaboration, and data-driven innovation, community health programs are ensuring resources are used more effectively and patient care is proactive rather than reactive. The post How Community Health Programs are Reducing […]
- Bridging the AI Gap in Local Health: Practical Steps for Adoptionby John Auerbach and Eddie Kirkland (MedCity News) on March 28, 2025
By prioritizing staff education, starting small with practical applications, and establishing clear guidelines, local health departments can lay the foundation for sustainable AI adoption. This approach ultimately enhances efficiency, improves […]